Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
I
IMMB
vs
S&P 500
S&P 500
Over the past 12 months, IMMB has significantly outperformed S&P 500, delivering a return of +100% compared to S&P 500's +10% growth.
Stocks Performance
IMMB vs S&P 500
Performance Gap
IMMB vs S&P 500
Performance By Year
IMMB vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Immunotech Laboratories Inc
Glance View
Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.